Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance
Cells · 2024
DOI: 10.3390/cells13161332 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Young Keun Hwang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Hauptthemen laut MEDLINE: Autophagy, Glioblastoma, Temozolomide, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government, Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government, The Catholic University of Korea Uijeongbu St. Mary’s Hospital Clinical Research Laboratory Foundation.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most aggressive and common malignant and CNS tumor, accounting for 47.7% of total cases. Glioblastoma has an incidence rate of 3.21 cases per 100,000 people. The regulation of autophagy, a conserved cellular process involved in the degradation and recycling of cellular components, has been found to play an important role in GBM pathogenesis and response to therapy. Autophagy plays a dual role in promoting tumor survival and apoptosis, and here we discuss the complex interplay between autophagy and GBM. We summarize the mechanisms underlying autophagy dysregulation in GBM, including PI3K/AKT/mTOR signaling, which is most active in brain tumors, and EGFR and mutant EGFRvIII. We also review potential therapeutic strategies that target autophagy for the treatment of GBM, such as autophagy inhibitors used in combination with the standard of care, TMZ. We discuss our current understanding of how autophagy is involved in TMZ resistance and its role in glioblastoma development and survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Industry-Academic Cooperation Foundation, The Catholic University of Korea, 222, Banpo-daro, Seocho-gu, Seoul 06591, Republic of Korea.
- Department of Neurosurgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Young Keun Hwang, Dong-Hun Lee, Jae Sang Oh
Förderung
- Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government
- Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government
- The Catholic University of Korea Uijeongbu St. Mary’s Hospital Clinical Research Laboratory Foundation
Zitieren
APA
Hwang, Y. K., Lee, D. H., Lee, E. C., & Oh, J. S. (2024). Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance. Cells. https://doi.org/10.3390/cells13161332
Vancouver
Hwang YK, Lee DH, Lee EC, Oh JS. Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance. Cells. 2024. doi:10.3390/cells13161332
BibTeX
@article{Hwang2024,
author = {Hwang, Young Keun and Lee, Dong-Hun and Lee, Eun Chae and Oh, Jae Sang},
title = {Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13161332}
}
EUVIMED